Skip to content

The LMA-Supreme as an airway intubation conduit in patients with a difficult airway - A feasibility study

The LMA-Supreme as an airway intubation conduit in patients with a difficult airway - A feasibility study - The LMA-Supreme as intubation conduit.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36131
Enrollment
25
Registered
2011-03-01
Start date
2011-03-15
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patiënten die een chirurgische ingreep ondergaan onder narcose met een endotracheale intubatie Difficult intubation

Interventions

Insertion of a laryngeal mask in stead of direct laryngoscopy and intubation. Via the laryngeal mask a fiberscope is inserted to visualise the vocal cords. Once the vocal cords are visualized the end

Sponsors

Catharina-ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients who will undergo general surgery and anaesthesia, for which endotracheal intubation is essential

Exclusion criteria

Exclusion criteria: age

Design outcomes

Primary

MeasureTime frame
Successful insertion of an endotracheal tube in the trachea using a laryngeal mask as intubation conduit. Effective airway time

Secondary

MeasureTime frame
number of intubation attempts verification of correct position endotracheal tube (via fibreoptic scope) measurement of gastric content (via nasogastric tube drain) At the time of removal of the laryngeal mask, the presence of blood, gastric content and/or pathology is noted, including any mouth, lip or tongue injury. Patients are assessed in the recovery room 2 h after surgery by an observer, instructed in airway morbidity scoring (sore throat/hoarseness, dysphagia, dysphonia), and symptoms are graded by the patient from 0 (no) till 3 (severe).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)